Literature DB >> 507192

The selection and characterization of an invasive variant of the B16 melanoma.

I R Hart.   

Abstract

Several in vitro properties of two variant cell lines of the B16 melanoma (B16-F10 and B16-BL6) with markedly different spontaneous metastatic behavior were examined. The two cell lines were compared with regard to their in vitro growth rate, ability to migrate, ability to adhere to a variety of substrata, detachment rates, production of plasminogen activator, and cell surface proteins as determined by lactoperoxidase-catalyzed iodination. Growth rates in vitro, attachment rates, and qualitative patterns of cell surface proteins were almost identical. B16-F10 cells (the less spontaneously metastatic line) produced greater amounts of plasminogen activator, were more motile in vitro, and detached more readily from plastic than the more invasive B16-BL6 cells. The study of tumor cell variants, selected for different biologic behavior, is a valuable approach to the elucidation of those mechanisms responsible for their malignant activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507192      PMCID: PMC2042430     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  EXPERIMENTAL STUDIES OF THE INTRAVASCULAR DISSEMINATION OF ASCITIC V2 CARCINOMA CELLS IN THE RABBIT, WITH SPECIAL REFERENCE TO FIBRINOGEN AND FIBRINOLYTIC AGENTS.

Authors:  J R WOODS
Journal:  Bull Schweiz Akad Med Wiss       Date:  1964-05

2.  Degradation of basement membrane by murine tumor cells.

Authors:  L A Liotta; J Kleinerman; P Catanzaro; D Rynbrandt
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Chick embryonic skin as a rapid organ culture assay for cellular neoplasia.

Authors:  P D Noguchi; J B Johnson; R O'Donnell; J C Petricciani
Journal:  Science       Date:  1978-03-03       Impact factor: 47.728

Review 5.  Cell interactions in the metastatic process: some cell surface properties associated with successful blood-borne tumor spread.

Authors:  G L Nicolson; C R Birdwell; K W Brunson; J C Robbins; G Beattie; I J Fidler
Journal:  Soc Gen Physiol Ser       Date:  1977

6.  Comparison of subpopulations of tumor cells with altered migratory activity, attachment characteristics, enzyme levels and in vivo behavior.

Authors:  J Varani; W Orr; P A Ward
Journal:  Eur J Cancer       Date:  1979-04       Impact factor: 9.162

7.  Isolation and metastatic properties of detachment variants of B16 melanoma cells.

Authors:  E B Briles; S Kornfeld
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

Review 8.  Tumor heterogeneity and the biology of cancer invasion and metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

Review 9.  Specificity of arrest, survival, and growth of selected metastatic variant cell lines.

Authors:  G L Nicolson; K W Brunson; I J Fidler
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

10.  Lactoperoxidase catalyzed radioiodination of cell surface immunoglobulin: incorporated radioactivity may not reflect relative cell surface Ig density.

Authors:  R L Wilder; C C Yuen; R G Mage
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

View more
  116 in total

1.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.

Authors:  Akihiko Ito; Yu-ichiro Koma; Miwa Sohda; Kenji Watabe; Teruaki Nagano; Yoshio Misumi; Hiroshi Nojima; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 3.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

4.  Modulation of clonal progression in B16F1 melanoma cells.

Authors:  J F Harris; A F Chambers; A S Tam
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

5.  A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.

Authors:  M Blackmore; S Thompson; G A Turner
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

6.  Immunomodulatory and therapeutic properties of FK-565 in mice.

Authors:  J E Talmadge; B Lenz; M Schneider; H Phillips; C Long
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Authors:  Megumi Morimoto-Tomita; Yoshimi Ohashi; Azusa Matsubara; Makoto Tsuiji; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.

Authors:  G Poste; J Tzeng; J Doll; R Greig; D Rieman; I Zeidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain.

Authors:  Chenyu Zhang; Fahao Zhang; Rachel Tsan; Isaiah J Fidler
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

10.  Laminin production by murine melanoma cells: possible involvement in cell motility.

Authors:  S E Fligiel; K A Laybourn; B P Peters; R W Ruddon; J C Hiserodt; J Varani
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.